New Concepts and Emerging Therapies in Metabolic Disorders and Vasuclar Disease is a conference that covers topics such as:
- Rationale therapies for the treatment of dementia
- The pathophysiology of atherosclerosis and dementia
- The critical timing hypothesis atherosclerosis in post-menopausal women
- Results of menopausal hormone therapy trials and implications for cardioprotection
- New therapies and choose the appropriate work up for patients with diabetic dyslipidemia
- The clinical course, epidemiology, and currently recommended therapies for diabetic nephropathy
- Implementation of heart disease preventive therapies in women
- A cardiovascular disease risk assessment in women
- Alcoholic liver disease using blood tests, imaging, and liver biopsy
- Pathophysiology of hypertension and vascular dementia and what the effect of anti-hypertensive therapy has on cognitive function
- Pathophysiology and treatment of erectile dysfunction
- Nutritional support in the medical management of alcoholic liver disease
- Diagnosis and management of fatty liver disease
- Clinical features associated with fatty liver and the risk factors associated with the progression to nonalcoholic teatohepatitis (NASH) and cirrhosis
- New cardiac and peripheral interventions in patients with diabetes and renal failure
New Concepts and Emerging Therapies in Metabolic Disorders and Vasuclar Disease brings together physicians and pharmacists in general medicine, primary care, cardiologists, endocrinologists, and internal medicine. registered dieticians, Physician assistants, nurse practitioners and nurses and other health-care team members.
